Long-Term Efficacy Of Nintedanib Is Maintained In Patients With Idiopathic Pulmonary Fibrosis (ipf) Irrespective Of Dose: Subgroup Analysis Of Inpulsis-On Conferences

Overview
Research
Additional Document Info
View All

authors

Crestani, B
Kolb, Martin Rainer
Wallaert, B
Quaresma, M
Stansen, W
Richeldi, L

status

published

publication date

January 1, 2017

has subject area

11 Medical and Health Sciences (FoR)
Respiratory System (Science Metrix)

published in

American Journal of Respiratory and Critical Care Medicine Journal

presented at event

International Conference of the American-Thoracic-Society (ATS) Conference